Sanofi will be at the Diabetes UK Professional Conference (DUK) on 22-24 April 2026 in full force.
Come and learn about Tzield (teplizumab) at stand A30.
Our non-promotional team will also be in attendance, at stand F12.
What to expect
Our Tzield Gallery
Come and see us at stands A30 and F12
Visit our Tzield Gallery to learn about Tzield; what it is, how it works and why it represents a new era in autoimmune type 1 diabetes (T1D). Come away with new knowledge on this disease-modifying therapy and importantly how an infusion service could be implemented in your locality. Look out for our striking glass-walled Service Studio (aka The Cube).
Our Symposium
Infusion Implementation in Type 1 Diabetes
A practical symposium for healthcare professionals on implementing disease-modifying therapy for stage 2 type 1 diabetes. Learn from patient stories, review the clinical rationale, and gain actionable steps to establish this service in your trust.
Speaker: Dr Ruben Willemsen, Consultant in Paediatric Diabetes and Endocrinology and the Clinical Lead for the Paediatric Diabetes Service at the Royal London Children's Hospital, Barts Health NHS Trust.
Chair: Dr Tabitha Randell, Consultant in Paediatric Endocrinology and Diabetes at Nottingham Children's Hospital.
Date: Wednesday 22nd April 2026, 17:25 – 18:25
Speaker: Ahmad Ashour, Senior Clinical Pharmacist, Independent Prescriber and NICU Lead Pharmacist at Barts Health NHS Trust.
Location: Room 4, Exhibition Centre Liverpool
Our Theatre Talks
Anne Goodchild
Diabetes Specialist Nurse, director of DIME square Ltd and Founder of PITstop and Pre-PITstop.
Dr Naresh Kanumilli
GP with a Special Interest in Diabetes and Cardiology, Chair of the Primary Care Diabetes and Obesity Society.
Tamsin Fletcher-Salt
Lead Diabetes and Endocrinology Nurse for the University Hospital of North Midlands. Clinical Inpatient Diabetes Lead NHS Midlands Network.
Insulin Detemir Discontinuation: Clinical & Practical Guidance for Switching Patients to Alternative Basal Insulins
These interactive sessions will feature expert insights and case studies, looking at the clinical guidance as well as practical implementation.
Visit our Campus site to learn more about Tzield and learn how to start and switch insulin ahead of DUK
Unable to join us at DUK? Get your whole MDT ready to deliver the first Tzield infusion with confidence in your service with this practical full-day training, from infusion set up to patient communication. Register your interest below.
Location: Edgbaston Park Hotel, University of Birmingham
Get in Touch with Us
Questions? Leave your details and we'll reach out to you at your preferred time.
Get in touchINDICATION: TZIELD is indicated to delay the onset of Stage 3 T1D in adult and paediatric patients 8 years of age and older with Stage 2 T1D.1
- TZIELD® (teplizumab) UK Summary of Product Characteristics. 2025.
MAT-XU-2600576 (v1.0) | April 2026